Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neel K Sharma

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Health Physics|May 23, 2018
PEGylated IL-11 (BBT-059): A Novel Radiation Countermeasure for Hematopoietic Acute Radiation SyndromeVidya P Kumar, Shukla Biswas, Neel K Sharma, et al.
International Journal of Molecular Sciences|July 26, 2020
Dysregulated Cardiac IGF-1 Signaling and Antioxidant Response Are Associated with Radiation SensitivitySaeed Y Aghdam, Doreswamy Kenchegowda, Neel K Sharma, et al.
Frontiers in Surgery|November 24, 2022
Case report: Surgical resection of a retro-hepatic leiomyosarcoma involving atrial reconstruction, cardiopulmonary bypass, <i>ex vivo</i> tumor resection, and liver re-implantationNeel K Sharma, Uchenna Okakpu, Jeevan Murthy, et al.
Scientific Reports|February 19, 2014
Does DcR1 (TNF-related apoptosis-inducing-ligand Receptor 3) have any role in human AMD pathogenesis?Akshay Anand, Neel K Sharma, Ramandeep Singh, et al.
Scientific Reports|September 14, 2023
PEGylated thrombopoietin mimetic, JNJ‑26366821 a novel prophylactic radiation countermeasure for acute radiation injuryGregory P Holmes-Hampton, Vidya P Kumar, Shukla Biswas, et al.
Frontiers in Aging Neuroscience|January 21, 2020
Mitochondrial Degeneration and Autophagy Associated With Delayed Effects of Radiation in the Mouse BrainNeel K Sharma, Sasha Stone, Vidya P Kumar, et al.
Scientific Reports|April 24, 2020
Delayed effects of acute whole body lethal radiation exposure in mice pre-treated with BBT-059Neel K Sharma, Gregory P Holmes-Hampton, Vidya P Kumar, et al.
Molecular Cancer Therapeutics|October 30, 2025
Preclinical development of MGC028, an ADAM9-targeted, glycan-linked, exatecan-based antibody-drug conjugate for the treatment of solid cancersJuniper A Scribner, Jennifer G Brown, Thomas Son, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Health Physics|May 23, 2018
PEGylated IL-11 (BBT-059): A Novel Radiation Countermeasure for Hematopoietic Acute Radiation SyndromeVidya P Kumar, Shukla Biswas, Neel K Sharma, et al.
International Journal of Molecular Sciences|July 26, 2020
Dysregulated Cardiac IGF-1 Signaling and Antioxidant Response Are Associated with Radiation SensitivitySaeed Y Aghdam, Doreswamy Kenchegowda, Neel K Sharma, et al.
Frontiers in Surgery|November 24, 2022
Case report: Surgical resection of a retro-hepatic leiomyosarcoma involving atrial reconstruction, cardiopulmonary bypass, <i>ex vivo</i> tumor resection, and liver re-implantationNeel K Sharma, Uchenna Okakpu, Jeevan Murthy, et al.
Scientific Reports|February 19, 2014
Does DcR1 (TNF-related apoptosis-inducing-ligand Receptor 3) have any role in human AMD pathogenesis?Akshay Anand, Neel K Sharma, Ramandeep Singh, et al.
Scientific Reports|September 14, 2023
PEGylated thrombopoietin mimetic, JNJ‑26366821 a novel prophylactic radiation countermeasure for acute radiation injuryGregory P Holmes-Hampton, Vidya P Kumar, Shukla Biswas, et al.
Frontiers in Aging Neuroscience|January 21, 2020
Mitochondrial Degeneration and Autophagy Associated With Delayed Effects of Radiation in the Mouse BrainNeel K Sharma, Sasha Stone, Vidya P Kumar, et al.
Scientific Reports|April 24, 2020
Delayed effects of acute whole body lethal radiation exposure in mice pre-treated with BBT-059Neel K Sharma, Gregory P Holmes-Hampton, Vidya P Kumar, et al.
Molecular Cancer Therapeutics|October 30, 2025
Preclinical development of MGC028, an ADAM9-targeted, glycan-linked, exatecan-based antibody-drug conjugate for the treatment of solid cancersJuniper A Scribner, Jennifer G Brown, Thomas Son, et al.
Pageof 2